Leqvio

inclisiran

Approval

ApplicationNDA 214012
Approval dateDec 22, 2021
Approval year2021
SponsorNovartis

FDA-approved use

To treat heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease as an add-on therapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Leqvio: